Task: Answer the multiple choice question.
Question: Which drug exhibits a 18.023% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCn1c(SCC(=O)NC(C)c2ccccc2)nc2ccccc21
(b) CCOc1ccc(/C=N/NC(=O)c2ccc(Cn3cc(Br)cn3)o2)cc1
Answer: a. CCn1c(SCC(=O)NC(C)c2ccccc2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(SCC(=O)NC(C)c2ccccc2)nc2ccccc21
CCn1c(SCC(=O)NC(C)c2ccccc2)nc2ccccc21
2-(1-ethylbenzimidazol-2-yl)sulfanyl-N-(1-phenylethyl)acetamide